Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 7/20 | 0.44 |
| ▸ | NR1H4 | Q96RI1 | 5/20 | 0.44 |
| ▸ | P2RX7 | Q99572 | 4/20 | 0.36 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.36 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.35 |
| ▸ | TRPV1 | Q8NER1 | 4/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.34 |
| ▸ | PKM | P14618 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.34 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL794099 | 0.93 | EPHX2 (0.41) | EPHX2NR1H4P2RX7ENPP2HSD11B1 | |
| SCHEMBL15465958 | 0.93 | EPHX2 (0.42) | EPHX2NR1H4P2RX7ENPP2HSD11B1 | |
| SCHEMBL792802 | 0.92 | EPHX2 (0.39) | EPHX2NR1H4P2RX7ENPP2TRPV1 | |
| SCHEMBL794436 | 0.92 | EPHX2 (0.39) | EPHX2NR1H4P2RX7ENPP2TRPV1 | |
| SCHEMBL794407 | 0.91 | EPHX2 (0.45) | EPHX2NR1H4P2RX7ENPP2TRPV1 | |
| SCHEMBL27996611 | 0.89 | CYP2C9 (0.40) | EPHX2NR1H4ENPP2CYP2C19 | |
| SCHEMBL794397 | 0.88 | KCNH2 (0.44) | EPHX2NR1H4P2RX7CYP2D6PKM | |
| SCHEMBL807795 | 0.87 | EPHX2 (0.38) | EPHX2NR1H4P2RX7ENPP2TRPV1 | |
| SCHEMBL793993 | 0.86 | EPHX2 (0.40) | EPHX2NR1H4P2RX7ENPP2HSD11B1 | |
| SCHEMBL27996653 | 0.85 | EPHX2 (0.38) | EPHX2NR1H4P2RX7TRPV1CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9375000-B2 | Pesticidal arylpyrrolidines | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2016-06-28 | — | — | US | disclosed |
| CN-103282347-B | Pesticidal arylpyrrolidines | BAYER IP GMBH | 2015-04-01 | — | — | CN | disclosed |
| US-20140046069-A1 | PESTICIDAL ARYLPYRROLIDINES | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2014-02-13 | — | — | US | disclosed |
| EP-2616437-A1 | PESTICIDAL ARYLPYRROLIDINES | Bayer Intellectual Property GmbH (DE) | 2013-07-24 | — | — | EP | disclosed |
| WO-2012035011-A1 | PESTICIDAL ARYLPYRROLIDINES | BAYER CROPSCIENCE AG (DE) | 2012-03-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140046069-A1 | PESTICIDAL ARYLPYRROLIDINES | DDT, ACHE, CAT | EPHX2 1332/4885NR1H4 3054/4885P2RX7 750/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.